> Among the two cohorts with a previous COVID-19 diagnosis, no consistent incidence gradient by time since the previous diagnosis was observed (Supplementary Figure 3, https://stacks.cdc.gov/view/cdc/113253). When the vaccinated cohorts were stratified by the vaccine product received, among vaccinated persons without a previous COVID-19 diagnosis, the highest incidences were observed among persons receiving the Janssen (Johnson & Johnson), followed by Pfizer-BioNTech, then Moderna vaccines (Supplementary Figure 4, https://stacks.cdc.gov/view/cdc/113253). No pattern by product was observed among vaccinated persons with a previous COVID-19 diagnosis.
1) Natural immunity did not appear to wane over the study interval. (No difference in Hazard Ratio when stratifying by time since infection)
2) Vaccine only immunity showed major differences stratified across brands and time but if the person also had prior exposure then all differences disappear. Seems to indicate natural immunity is the heavy lifter here.
Of course they go on to blanket recommend vaccines but of course that was going to be the conclusion somehow.
Are you surprised that they recommend vaccines though? Even if natural immunity gave absolutely perfect immunity, it would make sense to recommend vaccines to the uninfected population.
I believe they go further than that, recommending vaccine to anyone unvaccinated (not just uninfected+unvaccinated). I may have misread, I don't think the study they present really justifies that reach as the difference between vaccinated and not vaccinated is not statistically significant when someone has already recovered. That is per their own evaluation as I've read it.
For one I am glad the CDC has finely ditched their two year long quest in undermining natural immunity. Sadly it may be too late, and I am certain that once this crisis peter out there will be a massive re-organizing (specially if the GOP takes back both Houses).
>During May–November 2021, case and
hospitalization rates were highest
among persons who were
unvaccinated without a previous
diagnosis. Before Delta became the
predominant variant in June, case rates were higher among persons
who survived a previous infection
than persons who were vaccinated
alone. By early October, persons who
survived a previous infection had
lower case rates than persons who were vaccinated alone.
And
>What are the implications for public health practice? Although the epidemiology of
COVID-19 might change as new
variants emerge, vaccination remains
the safest strategy for averting future
SARS-CoV-2 infections,
hospitalizations, long-term sequelae, and death. Primary vaccination,
additional doses, and booster doses
are recommended for all eligible
persons. Additional future
recommendations for vaccine doses
might be warranted as the virus and immunity levels change.
I wonder if an ideal vaccine would mimic natural infection. A natural infection grows and grows and grows until the immune system finally gets going and snuffs if out, over the course of days or weeks.
Perhaps a slow-release vaccine would work better than a multi dose regimen? Two or three huge doses doesn’t really mimic anything like what an infection actually looks like.
There's always a balancing act between vaccine safety and efficacy. The smallpox vaccine mimics a natural infection, but it's extremely dangerous because people who get vaccinated can actually spread real smallpox to others for a period of time, so they have to stay isolated.
Pre-Covid coronavirus vaccines tested in animals induced antibody-dependent enhancement and were thus deemed unsafe for human trials. A safe, effective Covid vaccine was always a long shot. Maybe one day we'll get one, but maybe we won't. Thankfully, there are multiple other drugs that are effective at preventing and treating Covid.
I find the final paragraph amazing of the mmwr:
> Among the two cohorts with a previous COVID-19 diagnosis, no consistent incidence gradient by time since the previous diagnosis was observed (Supplementary Figure 3, https://stacks.cdc.gov/view/cdc/113253). When the vaccinated cohorts were stratified by the vaccine product received, among vaccinated persons without a previous COVID-19 diagnosis, the highest incidences were observed among persons receiving the Janssen (Johnson & Johnson), followed by Pfizer-BioNTech, then Moderna vaccines (Supplementary Figure 4, https://stacks.cdc.gov/view/cdc/113253). No pattern by product was observed among vaccinated persons with a previous COVID-19 diagnosis.
1) Natural immunity did not appear to wane over the study interval. (No difference in Hazard Ratio when stratifying by time since infection)
2) Vaccine only immunity showed major differences stratified across brands and time but if the person also had prior exposure then all differences disappear. Seems to indicate natural immunity is the heavy lifter here.
Of course they go on to blanket recommend vaccines but of course that was going to be the conclusion somehow.